Longer duration of homelessness is associated with a lower likelihood of non-detectable plasma HIV-1 RNA viral load among people who use illicit drugs in a Canadian setting

References

• Arts, E. J., & Hazuda, D. J. (2012). HIV-1 antiretroviral drug therapy. Cold Spring Harbor Perspectives in Medicine, 2(4), a007161. doi:10.1101/cshperspect.a007161
   PubMed Web of Science ®Google Scholar
• Baggett, T. P., Hwang, S. W., O’Connell, J. J., Porneala, B. C., Stringfellow, E. J., Orav, E. J., … Rigotti, N. A. (2013). Mortality among homeless adults in Boston: Shifts in causes of death over a 15-year period. JAMA Internal Medicine, 173(3), 189–195. doi:10.1001/jamainternmed.2013.1604
   PubMed Web of Science ®Google Scholar
• Buchanan, D., Kee, R., Sadowski, L. S., & Garcia, D. (2009). The health impact of supportive housing for HIV-positive homeless patients: A randomized controlled trial. American Journal of Public Health, 99(Suppl. 3), S675–S680. doi:10.2105/AJPH.2008.137810
   PubMedGoogle Scholar
• Carballo, E., Cadarso-Suárez, C., Carrera, I., Fraga, J., Fuente, J. de la, Ocampo, A., … Prieto, A. (2004). Assessing relationships between health-related quality of life and adherence to antiretroviral therapy. Quality of Life Research, 13(3), 587–599. doi:10.1023/B:QURE.0000021315.93360.8b
   PubMed Web of Science ®Google Scholar
• Coe, A. B., Moczygemba, L. R., Gatewood, S. B. S., Osborn, R. D., Matzke, G. R., & Goode, J.-V. R. (2015). Medication adherence challenges among patients experiencing homelessness in a behavioral health clinic. Research in Social and Administrative Pharmacy, 11(3), e110–e120. doi:10.1016/j.sapharm.2012.11.004
   PubMed Web of Science ®Google Scholar
• Greenwood, R. M., Schaefer-McDaniel, N. J., Winkel, G., & Tsemberis, S. J. (2005). Decreasing psychiatric symptoms by increasing choice in services for adults with histories of homelessness. American Journal of Community Psychology, 36(3–4), 223–238. doi:10.1007/s10464-005-8617-z
   PubMed Web of Science ®Google Scholar
• Hawk, M., & Davis, D. (2012). The effects of a harm reduction housing program on the viral loads of homeless individuals living with HIV/AIDS. AIDS Care, 24(5), 577–582. doi:10.1080/09540121.2011.630352
   PubMed Web of Science ®Google Scholar
• Malta, M., Strathdee, S. A., Magnanini, M. M. F., & Bastos, F. I. (2008). Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: A systematic review. Addiction, 103(8), 1242–1257. doi:10.1111/j.1360-0443.2008.02269.x
   PubMed Web of Science ®Google Scholar
• Milloy, M.-J., Kerr, T., Bangsberg, D. R., Buxton, J., Parashar, S., Guillemi, S., … Wood, E. (2012). Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting. AIDS Patient Care and STDs, 26(1), 60–67. doi:10.1089/apc.2011.0169
   PubMed Web of Science ®Google Scholar
• Milloy, M. J., Kerr, T., Buxton, J., Rhodes, T., Guillemi, S., Hogg, R., … Wood, E. (2011). Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. Journal of Infectious Diseases, 203(9), 1215–1221. doi:10.1093/infdis/jir032
   PubMed Web of Science ®Google Scholar
• Milloy, M.-J., Marshall, B. D. L., Kerr, T., Buxton, J., Rhodes, T., Montaner, J., & Wood, E. (2012). Social and structural factors associated with HIV disease progression among illicit drug users: A systematic review. AIDS, 26(9), 1049–1063. doi:10.1097/QAD.0b013e32835221cc
   PubMed Web of Science ®Google Scholar
• Milloy, M.-J., Marshall, B. D. L., Montaner, J., & Wood, E. (2012). Housing status and the health of people living with HIV/AIDS. Current HIV/AIDS Reports, 9(4), 364–374. doi:10.1007/s11904-012-0137-5
   PubMed Web of Science ®Google Scholar
• Milloy, M.-J., Montaner, J., & Wood, E. (2012). Barriers to HIV treatment among people who use injection drugs: Implications for “treatment as prevention”. Current Opinion in HIV and AIDS, 7(4), 332–338. doi:10.1097/COH.0b013e328354bcc8
   PubMed Web of Science ®Google Scholar
• Montaner, J. S. G., Hogg, R., Wood, E., Kerr, T., Tyndall, M., Levy, A. R., & Harrigan, P. R. (2006). The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. The Lancet, 368(9534), 531–536. doi:10.1016/S0140-6736(06)69162-9
   PubMed Web of Science ®Google Scholar
• Montaner, J. S. G., Lima, V. D., Barrios, R., Yip, B., Wood, E., Kerr, T., … Kendall, P. (2010). Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: A population-based study. The Lancet, 376(9740), 532–539. doi:10.1016/S0140-6736(10)60936-1
   PubMed Web of Science ®Google Scholar
• Palepu, A., Milloy, M.-J., Kerr, T., Zhang, R., & Wood, E. (2011). Homelessness and adherence to antiretroviral therapy among a cohort of HIV-infected injection drug users. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 88(3), 545–555. doi:10.1007/s11524-011-9562-9
   PubMed Web of Science ®Google Scholar
• Riley, E. D., Moore, K. L., Haber, S., Neilands, T. B., Cohen, J., & Kral, A. H. (2011). Population-level effects of uninterrupted health insurance on services use among HIV-positive unstably housed adults. AIDS Care, 23(7), 822–830. doi:10.1080/09540121.2010.538660
   PubMed Web of Science ®Google Scholar
• Sayles, J. N., Rurangirwa, J., Kim, M., Kinsler, J., Oruga, R., & Janson, M. (2012). Operationalizing treatment as prevention in Los Angeles County: Antiretroviral therapy use and factors associated with unsuppressed viral load in the Ryan White system of care. AIDS Patient Care and STDs, 26(8), 463–470. doi:10.1089/apc.2012.0097
   PubMed Web of Science ®Google Scholar
• Schwarcz, S. K., Hsu, L. C., Vittinghoff, E., Vu, A., Bamberger, J. D., & Katz, M. H. (2009). Impact of housing on the survival of persons with AIDS. BMC Public Health, 9(1), 220. doi:10.1186/1471-2458-9-220
   PubMed Web of Science ®Google Scholar
• Somers, J. M., Moniruzzaman, A., & Palepu, A. (2015). Changes in daily substance use among people experiencing homelessness and mental illness: 24-month outcomes following randomization to Housing First or usual care. Addiction, 110(10), 1605–1614. doi:10.1111/add.13011
   PubMed Web of Science ®Google Scholar
• Tsemberis, S., & Elfenbein, C. (1999). A perspective on voluntary and involuntary outreach services for the homeless mentally ill. New Directions for Mental Health Services, 1999(82), 9–19. doi:10.1002/yd.23319998204
   Google Scholar
• Tsemberis, S., Gulcur, L., & Nakae, M. (2004). Housing First, consumer choice, and harm reduction for homeless individuals with a dual diagnosis. American Journal of Public Health, 94(4), 651–656. doi: 10.2105/AJPH.94.4.651
   PubMed Web of Science ®Google Scholar
• Waldrop-Valverde, D., & Valverde, E. (2005). Homelessness and psychological distress as contributors to antiretroviral nonadherence in HIV-positive injecting drug users. AIDS Patient Care and STDs, 19(5), 326–334. doi:10.1089/apc.2005.19.326
   PubMed Web of Science ®Google Scholar
• Wolfe, D., Carrieri, M. P., & Shepard, D. (2010). Treatment and care for injecting drug users with HIV infection: A review of barriers and ways forward. The Lancet, 376(9738), 355–366. doi:10.1016/S0140-6736(10)60832-X
   PubMed Web of Science ®Google Scholar
• Wolitski, R. J., Kidder, D. P., Pals, S. L., Royal, S., Aidala, A., Stall, R., … Housing and Health Study Team. (2010). Randomized trial of the effects of housing assistance on the health and risk behaviors of homeless and unstably housed people living with HIV. AIDS and Behavior, 14(3), 493–503. doi:10.1007/s10461-009-9643-x
   PubMed Web of Science ®Google Scholar
• Wood, E., Hogg, R. S., Lima, V. D., Kerr, T., Yip, B., Marshall, B. D. L., & Montaner, J. S. G. (2008). Highly active antiretroviral therapy and survival in HIV-infected injection drug users. JAMA, 300(5), 550–554. doi:10.1001/jama.300.5.550
   PubMed Web of Science ®Google Scholar
• Wood, E., Milloy, M. J., & Montaner, J. S. G. (2012). HIV treatment as prevention among injection drug users. Current Opinion in HIV and AIDS, 7(2), 151–156. doi:10.1097/COH.0b013e32834f9927
   PubMed Web of Science ®Google Scholar
• Wood, E., Montaner, J. S. G., Yip, B., Tyndall, M. W., Schechter, M. T., O’Shaughnessy, M. V., & Hogg, R. S. (2003). Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. Canadian Medical Association Journal, 169(7), 656–661.
   PubMed Web of Science ®Google Scholar